Health Care & Life Sciences » Pharmaceuticals | Piramal Enterprises Ltd.

Piramal Enterprises Ltd. | Mutual Funds

Mutual Funds that own Piramal Enterprises Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Aberdeen Global - Indian Equity Fund
2,559,590
1.42%
0
5.05%
05/31/2018
Vanguard Emerging Markets Stock Index Fund
1,370,587
0.76%
-9,100
0.08%
07/31/2018
Vanguard Total International Stock Index Fund
1,206,484
0.67%
22,598
0.02%
07/31/2018
Aberdeen India Fund
898,503
0.5%
-133,762
4.79%
03/31/2018
iShares MSCI India ETF
844,948
0.47%
-2,079
0.7%
09/06/2018
iShares Core MSCI Emerging Markets ETF
734,361
0.41%
0
0.07%
09/05/2018
DFA Dimensional Emerging Markets Value Fund
675,121
0.37%
-31,839
0.16%
01/31/2018
Aberdeen Global - Asian Smaller Companies Fund
568,755
0.32%
-159,000
1.7%
05/31/2018
Aberdeen Global - Emerging Markets Smaller Companies Fund
544,576
0.3%
0
3.28%
05/31/2018
American Funds New World Fund
525,949
0.28%
0
0.07%
06/30/2018

About Piramal Enterprises

View Profile
Address
Piramal Ananta
Mumbai Maharashtra 400070
India
Employees -
Website http://www.piramal.com
Updated 09/14/2018
Piramal Enterprises Ltd. engages in the business of pharmaceuticals and provision of financial services. It operates through the following segments: Pharmaceuticals Manufacturing and Services, Financial Services, and Healthcare Insights and Analytics. The Pharmaceuticals Manufacturing and Services segment operates through the following divisions: Pharma Solutions, Critical Care, Consumer Products Services and Imaging.